Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Santhera Pharmaceuticals Holding AG    SANN   CH0027148649

SANTHERA PHARMACEUTICALS HOLDING AG

(SANN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG (Santhera) is a Switzerland-based company engaged in the pharmaceutical sector. The Company is involved in the research, development and commercialization of pharmaceutical products for the treatment of neuromuscular and mitochondrial diseases. The Company’s products include Catena and Raxone brands, which are primarily implemented in the symptomatic treatment of Leber's Hereditary Optic Neuropathy (LHON) diseases. Sathera Pharmaceuticals Holding AG operates through its wholly owned subsidiaries: Santhera Pharmaceuticals (Schweiz) AG, Liestal, Santhera Pharmaceuticals (USA) Inc, Santhera Pharmaceuticals (Canada) Inc, Santhera Pharmaceutical (Deutschland) GmbH and Oy Santhera Pharmaceuticals (Finland) Ltd.

Number of employees : 117 people.
Sales per Business
20182019Delta
CHF (in Million)%CHF (in Million)%
Pharmaceutical Products31.66100%75.38100% +138.1%
Sales per region
20182019Delta
CHF (in Million)%CHF (in Million)%
European Union31.5499.6%75.1899.7% +138.33%
Rest of the World0.1130.4%0.1960.3% +73.45%
Managers
NameAgeSinceTitle
Dario Eklund512019Chief Executive Officer
Elmar J. Schnee, Dr.602017Chairman
Andrew P. Smith, Dr.562020Chief Financial Officer
Kristina Sjöblom Nygren, Dr.582017Chief Medical Officer, EVP & Head-Development
Thomas Meier, Dr.572019Director
Martin Gertsch552017Vice Chairman
Philipp Gutzwiller512017Independent Director
Patrick Volkert Vink, Dr.562017Independent Director
Oliver Strub562006Secretary, Executive VP & General Counsel
Günther Metz, Dr.612004Senior Vice President-Business Development
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 18,983,321 16,346,281 86.1% 54,892 0.3% 86.1%
Shareholders
NameEquities%
Idorsia Pharmaceuticals Ltd. 1,700,000 11.1%
Santhera Pharmaceuticals Holding AG 1,265,202 8.29%
Ernesto Bertarelli 759,371 4.98%
Ralf Arnold 331,350 2.17%
Fabrice Evangelista 250,379 1.64%
Credit Suisse Asset Management (Schweiz) AG 99,911 0.65%
Zürcher Kantonalbank (Investment Management) 98,851 0.65%
Thomas Meier 82,902 0.54%
UBS Asset Management Switzerland AG 73,750 0.48%
Rieter Fischer Partners AG 50,798 0.33%
Holdings
NameEquities%Valuation
Santhera Pharmaceuticals Holding AG (SANN) 1,265,2028.29%4,244,715 USD
Company contact information
Santhera Pharmaceuticals Holding AG
Hohenrainstrasse 24
Pratteln, Basel-Landschaft (Basle Country) 4133

Phone : +41.61.906.89.50
Fax : +41.61.906.89.51
Web : http://www.santhera.com